Most Popular
-
1
National Assembly speeds up efforts to outlaw dog meat consumption in S. Korea
-
2
'No Japan?' Korea swings from extreme rejection to selective embrace
-
3
A man's constitutional battle reignites 'death with dignity' debate
-
4
Heavy traffic jams on highways expected on 5th day of holiday
-
5
4 injured in rockfall at tourist attraction on eastern island of Ulleung
-
6
[Out of the Shadows] Tell the truth: Advanced drug education needed to curb teen exposure, experts say
-
7
US calls on China to encourage N. Korea's return to diplomacy
-
8
S. Koreans' happiness rising slowly but surely: presidential panel
-
9
[Herald Interview] When ‘comedy freak’ filmmaker makes rom-com '30 Days’
-
10
Shin-Hanul 2 nuclear reactor on test run for full operation next year
SK chairman discusses global health commitments with Gates
By Kan Hyeong-wooPublished : Aug. 16, 2022 - 17:49

According to officials, SK Discovery Executive Vice Chairman Chey Chang-won and SK Bioscience CEO Ahn Jae-yong also attended the meeting in Yeouido, western Seoul. The SK leaders and Gates talked about how they can cooperate to improve global health.
SK Bioscience said the company and the Bill and Melinda Gates Foundation have agreed to keep exploring methods to solve the global health problem and continue research and development efforts for new treatments and vaccines to respond to the next pandemic.
SK Bioscience has partnered with the Bill and Melinda Gates Foundation since 2013. The foundation provided funding for the South Korean vaccine developer’s efforts to create a number of products including a typhoid vaccine and nonreplicating rotavirus vaccine.
SK Bioscience received $3.6 million from the foundation to develop SKYCovieone, the country’s first domestic COVID-19 vaccine. With the funding, the company is also currently developing an antiviral nasal spray to prevent COVID-19 infections.